Author/year | Patients (number) | Depth of bowel wall involvement (%) | Mesenteric nodal involvement (%) | Prognostic significance of pathological variables | Survival of optimally debulked patients |
---|---|---|---|---|---|
O’Hanlan[27](1995) | 66 | Serosa 41 | 72.7 | Trend for patients with mesenteric nodal involvement to fail sooner | 26 months |
Muscolaris 42 | |||||
Submucosa 14 | |||||
Mucosa 3 | |||||
Lax[28](1998) | 31 | Serosa 45 | 64.5 | Trend for patients with mesenteric nodal involvement to fail sooner | 21 months |
Muscolaris 36 | |||||
Mucosa 19 | |||||
Scarabelli[29](2000) | 66 | Muscolaris 100 | 37.9 | Prognostic significance of depth of bowel wall involvement at multivariate analysis for patients with mesenteric node metastases | 5 years |
42.2 % | |||||
Hertel[30](2001) | 73 | Serosa 38.5 | Not reported | Not reported | Not reported |
Muscolaris 42.4 | |||||
Mucosa 19.1 | |||||
Park[31](2006) | 46 | Serosa 71.7 | 15.2 | Prognostic significance of depth of bowel wall involvement only for disease-free survival | 32 months |
Muscolaris + mucosa 28.3 | |||||
Tebes[32](2006) | 99 | Serosa 33.3 | Not reported | Not reported | Not reported |
Muscolaris 39.4 | |||||
Submucosa 13.1 | |||||
Mucosa 14.2 | |||||
Salani[33](2007) | 31 | Serosa 48 | 93.5 | Not reported | Not reported |
Muscolaris 29 | |||||
Submucosa 7 | |||||
Mucosa 16 | |||||
Gallota[20](2011) | 71 | Serosa 45 | 51 | NO | 38 months overall |
Muscolaris 25.4 | |||||
Submucosa 12.7 | 30 months disease-free | ||||
Mucosa 16.9 | |||||
Baiocchi[34](2011) | 41 | Serosa 34.1 | 70.7 | Not reported | Not reported |
Muscolaris 31.7 | |||||
Submucosa 14.6 | |||||
Mucosa 19.5 | |||||
Gouy[35](2012) | 47 | Serosa 61.7 | 40.4 | NO | 4 years 60 % |
Muscolaris 19.1 | |||||
Submucosa 6.3 | |||||
Mucosa 12.7 | |||||
Present series | 52 | Serosa 25 | 42.3 | Prognostic significance of depth of bowel wall involvement at multivariate analysis | 35.5 months overall |
Muscolaris 67.3 | |||||
 |  | Mucosa 7.7 |  |  | 32.5 months disease-free |